Global Bioequivalence Studies Market Size, Share, Forecast to 2032

The Global Bioequivalence Studies Market Size is expected to reach USD 1451.7 million by 2032, at a CAGR of 8.2% during the forecast period 2023 to 2032.Bioequivalence studies are conducted to compare the pharmacokinetic parameters of two drug formulations to determine if they are interchangeable. These studies are essential for generic drug development and ensure that generic versions of a drug are therapeutically equivalent to the brand-name reference product.